Celularity, Inc. (CELU)
1.60
+0.22
(+15.94%)
USD |
NASDAQ |
Oct 02, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Celularity Net Income (Quarterly) : 0.675M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.675M |
| December 31, 2025 | -24.36M |
| September 30, 2025 | -23.08M |
| June 30, 2025 | -24.52M |
| March 31, 2025 | -19.82M |
| December 31, 2024 | -13.29M |
| September 30, 2024 | -16.10M |
| June 30, 2024 | -6.488M |
| March 31, 2024 | -22.01M |
| December 31, 2023 | 9.547M |
| September 30, 2023 | -93.88M |
| June 30, 2023 | -47.95M |
| March 31, 2023 | -64.02M |
| December 31, 2022 | 24.43M |
| September 30, 2022 | 4.799M |
| Date | Value |
|---|---|
| June 30, 2022 | 47.83M |
| March 31, 2022 | -62.87M |
| December 31, 2021 | -4.039M |
| September 30, 2021 | 49.94M |
| June 30, 2021 | -64.48M |
| March 31, 2021 | -81.54M |
| December 31, 2020 | 3.91M |
| September 30, 2020 | -46.32M |
| June 30, 2020 | -0.1436M |
| March 31, 2020 | 6.368M |
| December 31, 2019 | 4.123M |
| September 30, 2019 | 1.121M |
| June 30, 2019 | 0.6347M |
| March 31, 2019 | -0.0001M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -17.80M |
| Exicure, Inc. | -1.121M |
| Century Therapeutics, Inc. | -34.55M |
| Absci Corp. | -33.21M |
| Cardio Diagnostics Holdings, Inc. | -1.502M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.846M |
| Total Expenses (Quarterly) | 3.171M |
| EPS Diluted (Quarterly) | 0.0223 |
| Enterprise Value | 114.40M |
| Gross Profit Margin (Quarterly) | 20.70% |
| Profit Margin (Quarterly) | 17.55% |
| Earnings Yield | -170.1% |
| Normalized Earnings Yield | -154.89 |